- AdventHealth
Ryan Mizell, MD
Neurologist
Medical Director, Neuroimmunology
AdventHealth Neuroscience Institute
Multiple sclerosis (MS) is a chronic, neurologic disease affecting nearly one million people in the United States and potentially causing severe disability. Though there is no cure, the advances in medications for MS have shown to be effective in preventing relapses and lesions on MRI of the central nervous system. Despite advanced imaging techniques, MS can be a difficult disease to diagnose.
A young female presented to clinic for assessment. She first had symptoms of numbness that lasted over several months. After undergoing MRI of the brain in 2019, she was not given a diagnosis.
In 2021, she began to develop numbness in her right arm and hands that progressed over one month to encompass her left arm and hands. She was seen at AdventHealth Neurology in Winter Park and underwent further testing that included MRI of the brain, cervical and thoracic spine. As her previous images were compared to her current images, she was found to have previous lesions in the brain located in the periventricular and infratentorial region of the brain, which are common locations for lesions of MS.
She had an actively enhancing juxtacortical lesion present in the left temporal region.
She underwent analysis of her cerebral spinal fluid, for which she had 15 oligoclonal bands, a test that is positive in patients with MS approximately 90-95% of the time.
After discussing the diagnosis, further conversations involved the recommendations to start a medication to treat MS with the goal of preventing relapses, new lesions, and disability. After a thorough discussion of the risks and benefits of different medications, she agreed to start ocrelizumab, a medication that is infused every six months and is used to treat patients with relapsing-remitting MS and primary-progressive MS. She continues to follow at the AdventHealth Neurology in Winter Park and remains relapse free on her current therapy.
Recent News
Physician leaders from AdventHealth’s emergency department, infectious disease, inpatient, pediatrics and pharmacy teams all collaborated to develop a respiratory virus testing algorithm to assist...
Thoracic surgeon Colleen Gaughan, MD, and her team at AdventHealth Celebration, recently became one of the first in the country to incorporate targeted imaging agent Cytalux (pafolacianine) as part of...
On the newest Inspiring Wholeness podcast, Obie Diaz, local morning radio show host, shares how a routine physical eventually led to two open heart surgeries.
AdventHealth recently began piloting a new Genomics Risk Assessment for Cancer and Early Detection (GRACE) program that combines the use of digital mammography, artificial intelligence (AI) technology...
AdventHealth Clinical Research Unit (CRU) Executive Director and Medical Director of Genitourinary Oncology Guru Sonpavde, MD, co-authored an article on the AMBASSADOR Phase III clinical trial results...
AdventHealth is accelerating the use of research-backed best practices for treating pediatric respiratory infections to combat antibiotic resistance and improve patient outcomes.
AdventHealth is accelerating the use of research-backed best practices for treating pediatric respiratory infections to combat antibiotic resistance and improve patient outcomes.
AdventHealth Research Institute is currently seeking physicians experiencing exhaustion, irritability, hopelessness, anxiety, work/home imbalance or similar burnout symptoms to participate in a...
A promising new treatment for AFib patients called Pulse Field Ablation is first offered in Central Florida at AdventHealth and shows less damage to tissue.
Plastic and Reconstructive Microsurgeon Sabrina Pavri, MD, and Breast Surgeon Devina McCray, MD, recently began offering immediate neurotization after breast reconstruction, a new surgical technique...
Explore the importance of Hispanic representation in our community in this episode of the Inspiring Wholeness podcast.
Under the leadership of gynecologist and gynecological surgeon Omar Zwain, MD, AdventHealth for Women opened its new, multidisciplinary Comprehensive Fibroid Program at AdventHealth Winter Park in...